{
    "nctId": "NCT06295744",
    "briefTitle": "Outcomes and Cosmesis With Whole Breast Irradiation and Boost",
    "officialTitle": "Patient-Reported Outcomes and Cosmesis Following Five Fraction Whole Breast Irradiation With Simultaneous Integrated Boost",
    "overallStatus": "RECRUITING",
    "conditions": "Early-stage Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Harvard Breast Cosmesis Scale Score",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Ability to understand and the willingness to sign a written informed consent document\n* Histologically confirmed early stage (stage T1-T2) invasive carcinoma of the breast or DCIS\n* Breast conserving surgery with negative margins and negative nodes (surgical axillary staging not mandatory), stage N0 or Nx\n* Treatment plan should include breast conserving surgery and adjuvant whole breast irradiation (WBI) therapy delivered with 3D-CRT or IMRT techniques\n* Treatment plan includes breast tumor bed boost\n* Willingness to comply with all study procedures and be available for the duration of the study\n\nExclusion Criteria:\n\n* Mastectomy of ipsilateral breast\n* Lack of histologic diagnosis\n* Histologic involvement of the axillary or regional nodes or metastatic disease\n* Accelerated partial breast irradiation treatment plan\n* Previous history of non-breast malignancy diagnosed in the past 5 years except for basal or squamous cell cancer of the skin\n* Previous history of chest radiation therapy\n* Previous history of ipsilateral breast cancer\n* Concurrent cytotoxic chemotherapy\n* Active connective tissue disease including scleroderma\n* Inability or unwillingness to return for required follow up visit",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}